Filing Flows › Arcutis Biotherapeutics (ARQT) › Net income
Arcutis Biotherapeutics (ARQT) net income by quarter
Arcutis Biotherapeutics' net income was $8.8M in Q3 2026 (third quarter 2026), -41% from Q2 2026. Over the last 4 quarters it ranged from $7.4M (Q3 2025) to $17.4M (Q4 2025).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $8.8M | -41% | +19% |
| Q2 2026 | $15.0M | -14% | — |
| Q4 2025 | $17.4M | +135% | — |
| Q3 2025 | $7.4M | — | — |
Q3 2026 at a glance
Arcutis Biotherapeutics, Q3 2026: revenue $144M (+45% year over year), operating margin 6.6%, net earnings $8.8M, operating cash flow $18.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is Arcutis Biotherapeutics' net income?
Arcutis Biotherapeutics' net income was $8.8M in Q3 2026 (third quarter 2026), -41% from Q2 2026.
How has Arcutis Biotherapeutics' net income changed?
Over the last 4 quarters it ranged from $7.4M (Q3 2025) to $17.4M (Q4 2025).
Q3 2026 results → · How Arcutis Biotherapeutics makes money →